Scientists Describe Type IV CRISPR-Cas SystemOctober 5, 2022
A research group at the Philipps University of Marburg in Germany reports that the soil bacterium Pseudomonas oleovorans uses a natural CRISPR-Cas system that is suitable for controlling gene activity. The researchers characterized the last type of bacterial CRISPR-Cas system that has not been described.
Marburg geneticist Professor Dr. Lennart Randau, who led the research work said that so far, six types of CRISPR-Cas systems have been distinguished by scientists. Most of these systems consist of well-characterized molecules with only type IV still a mystery relating to its natural activity in bacterial cells. Randau and his team looked at the type IV CRISPR-Cas system from P. oleovorans. The scientists monitored the activity of the CRISPR-Cas system in the original host but also transplanted it into the bacterium Escherichia coli.
The team found that the type IV CRISPR-Cas system targets double-stranded DNA as a substrate and requires a well-defined recognition sequence, which is also known from the other types. However, it does not cut the DNA. The research group found that type IV CRISPR-Cas is better suited to controlling the activity of its own Pseudomonas genes instead of cutting up invading genetic material.
For more details, read the article on the Philipps University of Marburg website.
You might also like:
- Scientist Introduces CRISPR 3.0 System for Highly Efficient Gene Activation in Plants
- Cas-CLOVER, an Alternative to CRISPR-Cas9
- Pocket K No. 54: Plant Breeding Innovation: CRISPR-Cas9
Biotech Updates is a weekly newsletter of ISAAA, a not-for-profit organization. It is distributed for free to over 22,000 subscribers worldwide to inform them about the key developments in biosciences, especially in biotechnology. Your support will help us in our mission to feed the world with knowledge. You can help by donating as little as $10.
See more articles:
Research and Tools
- Researchers Characterize Brassinosteroid Biosynthesis Genes in Rice
- ISAAA and Partners Call for Responsive Regulation of NBT Products
- Gene Editing to Help Curb Sterility Paradox in Fish Production
- CRISPR System Successfully Edits Fusarium Species
- Scientists Describe Type IV CRISPR-Cas System
Public Acceptance and Engagement
- EU Consultation Confirms Europeans' Support for Policy Change on Novel Genomic Techniques
Read the latest:
- Biotech Updates (November 29, 2023)
- Gene Editing Supplement (November 29, 2023)
- Gene Drive Supplement (February 22, 2023)
Subscribe to BU: